Monoclonal Gammopathy of Thrombotic Significance

SIMPLE SUMMARY: It is being increasingly recognized that patients with monoclonal gammopathy (MG) who do not meet criteria for malignant disease and treatment initiation may have other manifestations that are linked to the unique properties of the monoclonal protein that are clinically significant a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gkalea, Vasiliki, Fotiou, Despina, Dimopoulos, Meletios Athanasios, Kastritis, Efstathios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856365/
https://www.ncbi.nlm.nih.gov/pubmed/36672429
http://dx.doi.org/10.3390/cancers15020480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856365/
https://www.ncbi.nlm.nih.gov/pubmed/36672429
http://dx.doi.org/10.3390/cancers15020480

Ejemplares similares